Daihan Pharmaceutical Co.,Ltd. (KOSDAQ: 023910)

Daihan Pharmaceutical Co.,Ltd. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	152,880	163,170	183,600	172,200	197,700	189,900
Market Cap Growth	0.90%	-11.13%	6.62%	-12.90%	4.11%	-17.47%
Enterprise Value	86,020	60,093	96,028	117,564	155,174	170,968
Last Close Price	26000.00	27750.00	29778.89	27334.65	30945.08	29345.53
PE Ratio	5.09	5.74	7.14	7.24	10.68	6.25
PS Ratio	0.77	0.83	1.00	1.00	1.19	1.13
PB Ratio	0.59	0.66	0.81	0.85	1.09	1.14
P/FCF Ratio	12.18	9.28	9.01	5.99	6.99	10.57
P/OCF Ratio	4.52	4.20	6.33	4.24	5.88	5.39
EV/Sales Ratio	0.43	0.31	0.52	0.69	0.93	1.01
EV/EBITDA Ratio	1.95	1.35	2.28	2.90	3.76	3.85
EV/EBIT Ratio	2.38	1.68	2.91	4.04	5.18	5.08
EV/FCF Ratio	6.85	3.42	4.71	4.09	5.49	9.52
Debt / Equity Ratio	-	-	0.03	0.12	0.16	0.19
Debt / EBITDA Ratio	-	-	0.15	0.58	0.70	0.72
Debt / FCF Ratio	-	-	0.32	0.82	1.02	1.77
Asset Turnover	0.68	0.69	0.67	0.65	0.66	0.70
Inventory Turnover	4.81	5.38	5.46	5.22	5.03	5.37
Quick Ratio	2.46	3.28	3.04	2.72	2.46	2.11
Current Ratio	3.23	3.87	3.65	3.20	3.10	2.60
Return on Equity (ROE)	12.11%	12.01%	11.66%	11.79%	9.97%	18.34%
Return on Assets (ROA)	7.75%	7.83%	7.50%	6.91%	7.49%	8.73%
Return on Capital (ROIC)	9.12%	9.32%	8.99%	8.31%	9.15%	11.14%
Earnings Yield	19.65%	17.42%	13.60%	13.17%	8.79%	14.83%
FCF Yield	8.21%	10.77%	11.10%	16.71%	14.30%	9.46%
Payout Ratio	14.41%	13.20%	8.45%	9.30%	12.13%	5.83%
Buyback Yield / Dilution	0.74%	1.74%	0.27%	-0.02%	0.02%	-0.01%
Total Shareholder Return	3.63%	1.74%	0.27%	-0.02%	0.02%	-0.01%

Source: S&P Capital IQ. Standard template. Financial Sources.